100%(2)Il 100% ha trovato utile questo documento (2 voti)
9K visualizzazioni1 pagina
Terbutaline sulfate is a beta2-selective adrenergic agonist used for bronchodilation to treat and prevent bronchial asthma and reversible bronchospasm. It works by relaxing the smooth muscles of the bronchioles. Common side effects include restlessness, anxiety, tremors, and cardiac arrhythmias. Nurses should observe for signs of hypersensitivity, contraindications, and adverse drug reactions. They educate patients on proper administration and side effects while monitoring for 30 minutes after each dose.
Terbutaline sulfate is a beta2-selective adrenergic agonist used for bronchodilation to treat and prevent bronchial asthma and reversible bronchospasm. It works by relaxing the smooth muscles of the bronchioles. Common side effects include restlessness, anxiety, tremors, and cardiac arrhythmias. Nurses should observe for signs of hypersensitivity, contraindications, and adverse drug reactions. They educate patients on proper administration and side effects while monitoring for 30 minutes after each dose.
Copyright:
Attribution Non-Commercial (BY-NC)
Formati disponibili
Scarica in formato DOC, PDF, TXT o leggi online su Scribd
Terbutaline sulfate is a beta2-selective adrenergic agonist used for bronchodilation to treat and prevent bronchial asthma and reversible bronchospasm. It works by relaxing the smooth muscles of the bronchioles. Common side effects include restlessness, anxiety, tremors, and cardiac arrhythmias. Nurses should observe for signs of hypersensitivity, contraindications, and adverse drug reactions. They educate patients on proper administration and side effects while monitoring for 30 minutes after each dose.
Copyright:
Attribution Non-Commercial (BY-NC)
Formati disponibili
Scarica in formato DOC, PDF, TXT o leggi online su Scribd
Drug Data Classification Mechanism of Action Indication Contraindications Adverse Reaction Nursing Responsibilities
Generic Name Pharmacologic General Indications Concentrations CNS: Restlessness, Before
Terbutaline Class In low doses, acts relatively - Prophylaxis and - Hypersensitivity to apprehension, anxiety, fear, - Observe 15 rights of drug sulfate Beta2-selective selectively at beta2-adrenergic treatment of bronchial terbutaline CNS stimulation, hyperkinesia, administration. adrenergic receptors to cause asthma and reversible - Tachyarrhythmias, insomnia, tremor, drowsiness, - Reduce dosage with hepatic or Trade Name antagonist bronchodilation and relax the bronchospasm that tachycardia caused irritability, weakness, vertigo, renal failure. Brethine pregnant uterus; may occur with by digitalis headache, seizures - Assess for hypersensitivity to drug. Therapeutic At higher doses, beta2 bronchitis and intoxication - Assess for any contraindications to Minimum Dose Class selectively is lost and the drug emphysema, in - General anesthesia CV: Cardiac arrhythmias, the drug. 5 mg at 6-hr Antasthmatic, acts at beta1 receptors to cause patients 12 yr and with halogenated palpitations, angina pain, - Educate about side effects of intervals tid Bronchodilator, typical sympathomimetic older hydrocarbons or changes in BP and ECG drug. Sympathomimetic cardiac effects. - Unlabeled use: cyclopropane Maximum Dose , Tocolytic drug Tocolytic to prevent - Unstable vasomotor GI: Nausea, vomiting, During 15 mg/day Pharmacokinetics preterm labor system disorders heartburn, unusual or bad taste - Use minimal doses for minimal Pregnancy Risk - Labor and delivery in mouth periods of time, drug tolerance Contents Factor D: May cross placenta; enters - Lactation can occur with prolonged use. Terbutaline B breast milk Respiratory: Respiratory - Keep a beta-blocker, such as Precaution atenolol, readily available in su M: Tissue difficulties, pulmonary edema, - Diabetes, Coronary case cardiac dysrhythmias lf E: Urine coughing, bronchospasm insufficiency, CAD, occur. at History of CVA, COPD - For oral forms, administer with e Rout Onset Peak Duratio Other: Sweating, pallor, e n patient, water to facilitate swallowing. flushing, muscle cramps, Oral 30 2-3 hr 4-8 hr Hyperthyroidism, - For parenteral forms, avoid Availability and elevated LFTs min History of seizure contact with the needle. color SubQ 5-15 30-60 1.5-4 hr disorder, - Stay with patient throughout - Tablets: 2.5, 5 min min Psychoneurotic mg whole duration of individuals, administration. - Injection: 1 Drug Half Life Hypertension mg/mL 2-4 hr After Drug interaction - Monitor client for at least 30 Routes of > Drug to drug administration minutes. - Increased likelihood - Arrange for regular follow-up, Oral of cardiac Subcutaneous including blood tests, to arrhythmias with evaluate effects. halogenated - Instruct to report chest pain, hydrocarbon dizziness, insomnia, weakness, anesthetics tremor or irregular heartbeat, - Risk of failure to respond to usual bronchospasms if dosage. combined with - Instruct to take medication as diuretics directed for the full course of - Increased risk of therapy, even if feeling better. hypokalemia and - Do not double dose. ECG changes with - Do proper documentation. MAOIs and TCAs
> Drug to food
- none reported Source: Source: Source: Source: Source: Source: Source: Karch, Amy: 2009 Karch, Amy: 2009 Karch, Amy: 2009 Lippincott’s Nursing Karch, Amy: 2009 Lippincott’s Karch, Amy: 2009 Karch, Amy: 2009 Lippincott’s Nursing Karch, Amy: 2009 Lippincott’s Nursing Lippincott’s Nursing Lippincott’s Nursing Drug Guide, pp. 1125-1126 Nursing Drug Guide, pp. 1126 Lippincott’s Nursing Drug Drug Guide, pp. 1126 Drug Guide, pp. 1127 Drug Guide, pp. 1125- Drug Guide, pp. 1125 Guide, pp. 1126 1126